BPG is committed to discovery and dissemination of knowledge
Editorial
Copyright: ©Author(s) 2026.
World J Cardiol. Jul 26, 2026; 18(7): 117872
Published online Jul 26, 2026. doi: 10.4330/wjc.117872
Table 1 5-year outcomes of NeoHexa vs contemporary drug-eluting stents
Stent system
Ref.
5-year major adverse cardiac event
5-year target lesion revascularization
Key feature
NeoHexaTrehan et al[1]4.32%1.76%Biodegradable polymer
OrsiroBIOFLOW V8.0%-18.0%5.9%Ultrathin struts (60 μm)
UltimasterCENTURY IIN/A9.4%Bioresorbable coating
CYPHERSORT OUT IV17.4%N/ADurable polymer
MiStentDESSOLVE I/II15.1%3.5%Crystalline sirolimus
XIENCESPIRIT II8.0%-15.0%4.0%-6.0%Cobalt-chromium everolimus-eluting stents


Write to the Help Desk